Opus Genetics IRD Q1 2025 Annual earnings
Reported May 15, 2025 · Before market open
Revenue estimate$3.4M
EPS estimate-$0.34
Next report
Aug 12, 2026 (in a month)Revenue estimate$2.6M
EPS estimate-$0.15
Financials
Q1 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Opus Genetics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Opus Genetics report Q1 2025 earnings?
- Opus Genetics (IRD) reported Q1 2025 earnings on May 15, 2025 before market open.
- What were Opus Genetics's Q1 2025 revenue and EPS?
- Opus Genetics reported revenue of $4.4M and diluted EPS of $-0.32 for Q1 2025.
- Did Opus Genetics beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $3.4M by $970.0K. EPS beat the consensus estimate of $-0.34 by $0.02.
- How did Opus Genetics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 155.4% from $1.7M a year earlier and diluted EPS declined 10.3% from $-0.29.
- Where can I find Opus Genetics's Q1 2025 SEC filings?
- You can read the 10-K periodic report (0001140361-25-011410) directly on SEC EDGAR. The filing index links above go to sec.gov.